Pharmaceutical manufacturing teams often spend months evaluating equipment—yet still end up with machines that don’t integrate well, cost too much to maintain, or create downstream compliance headaches. In this edition of Emma’s Equipment Edge, we take a deep dive into how to properly purchase pharmaceutical equipment, from blenders and tablet presses to bioreactors and filling systems. Whether you’re outfitting a new facility or upgrading a single unit operation, the right decision-making framework can save millions in lifecycle cost while improving GMP performance.
1. Start With a User Requirement Specification (URS)—Not a Catalog
Before comparing vendors, define a strong URS that clarifies what the equipment must do versus what is simply nice to have. A complete URS should include:
- Required throughput and batch size
- Cleaning approach (CIP/SIP, manual, hybrid)
- Materials of construction
- Environmental constraints (humidity, temperature, cleanroom class)
- Required regulatory standards (21 CFR Part 211, EU Annex 1, ICH Q9)
- Automation needs (SCADA, PLC, data historian, audit trails)
A well-written URS is referenced throughout the equipment lifecycle and helps prevent costly specification gaps during FAT/SAT and PQ. Regulatory guidance emphasizes that equipment must be “suitable for its intended use” under 21 CFR §211.63, which is best demonstrated when the URS is correctly aligned with process requirements.1
2. Conduct a True Total Cost of Ownership (TCO) Analysis
A common mistake is choosing the “cheapest” equipment up-front. Pharmaceutical operations require long-term thinking. TCO calculations should include:
- Initial purchase, crating, and installation costs
- Commissioning, IQ/OQ/PQ validation costs
- Spare parts and wear components
- Preventive maintenance schedules
- Downtime risks (mean time between failures)
- Utility consumption (electrical load, compressed air, WFI, nitrogen)
- Cleaning chemical demand (CIP 100/200, enzymatic detergents)
- Software licenses, cybersecurity patches, and automation support
According to an analysis by the International Society for Pharmaceutical Engineering (ISPE), maintenance and downtime can exceed 40% of total equipment lifetime cost for high-utilization bioprocessing assets.2
3. Evaluate Equipment for Cleaning, Cross-Contamination Control, and Data Integrity
Regardless of whether the equipment is used for oral solids, aseptic fill-finish, or clinical trial packaging, FDA expects clear strategies for:
- Cleanability (surface finishes, RA values, weld quality, drainability)
- Residue reduction after CIP/SIP cycles or manual cleaning
- Automation audit trails per 21 CFR Part 11
- Data backup, security, and access control
For equipment used in sterile or biologics manufacturing, the design should also support cRABS/Isolator integration, HEPA-filtered airflow, and contamination control strategies consistent with EU Annex 1 (2022).3
External reference (EU Annex 1 – Cleanroom & Contamination Control):
https://health.ec.europa.eu/system/files/2022-08/EU_Annex_1_GMP_cleanrooms_en.pdf
4. Ask Every Vendor These Five Questions
Before signing a quote, request written responses to these critical questions:
A. What is the equipment’s throughput at realistic operational conditions?
Vendors often share ideal numbers—ask for results under “worst acceptable” conditions.
B. What validation documentation is included?
FAT/SAT protocols, calibration certificates, steel certificates, wiring diagrams, software validation packages, and component traceability lists should be included.
C. What is the lead time for spare parts?
A machine is useless if a critical bearing has a 12-week lead time.
D. What are the known failure modes?
Good vendors disclose which parts typically fail first and how frequently.
E. Can we speak to three reference clients?
Preferably in the same manufacturing category (e.g., oral solid dose, injectables, biologics).
5. Case Example: What to Consider When Purchasing a High-Shear Granulator
Many readers ask Emma about choosing a high-shear granulator, so here is a real-world, practical checklist that applies:
- Bowl capacity & usable volume: Most units run at ~70% total volume.
- Impeller and chopper speeds: Higher flexibility is needed for multi-product facilities.
- Discharge port design: Prevents sticking, dead zones, and cleaning issues.
- Explosion protection: Required if using solvent-based wet granulation (ATEX compliance).
- Integrated PAT: NIR moisture sensors help control endpoint granulation consistency.
- CIP design & spray-ball pattern: Poor CIP design = long changeovers.
Well-designed granulators reduce blend variability, shorten drying times, and support multi-product operations with minimized risk of cross-contamination.4
6. Vetting Vendors: Due Diligence Checklist
Before issuing a PO, complete the following:
- GMP supplier audit (remote or on-site)
- Review ISO 9001/13485 certifications
- Confirm CE/UL compliance
- Verify material certificates (316L stainless steel, elastomer grade)
- Ensure documentation includes As-Built drawings, P&IDs, manuals, and wiring
- Require Factory Acceptance Test (FAT) with punch list resolution
- Require Site Acceptance Test (SAT) before final payment
For large capital equipment purchases, consider auditing the vendor’s subcontractors—many “OEMs” outsource fabrication without disclosing it.
7. Don’t Forget About Installation, Qualification, and Lifecycle Maintenance
Equipment ownership doesn’t end at purchase.
Plan for:
- Installation Qualification (IQ)
- Operational Qualification (OQ)
- Performance Qualification (PQ)
- Annual Calibration
- Preventive Maintenance Contracts
- Change Control Management
FDA routinely cites companies for insufficient equipment maintenance under 21 CFR §211.67.5
A well-structured lifecycle program helps avoid warning letters and costly deviations.
Conclusion
Choosing pharmaceutical equipment is far more than an engineering decision—it impacts compliance, safety, efficiency, and long-term cost. With a strong URS, a realistic TCO analysis, and rigorous vendor due diligence, your next equipment purchase can set your facility up for years of reliable GMP performance.
In future editions of Emma’s Equipment Edge, we’ll spotlight individual machines including tablet presses, coaters, freeze dryers, isolators, and more. So stay tuned.
References & Footnotes
\
- U.S. Food & Drug Administration. 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals. Equipment Design (§211.63). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211 ↩
- International Society for Pharmaceutical Engineering (ISPE). Maintenance & Reliability in Pharmaceutical Manufacturing. https://ispe.org/ ↩
- European Commission. EU GMP Annex 1: Manufacture of Sterile Medicinal Products (2022). https://health.ec.europa.eu/system/files/2022-08/EU_Annex_1_GMP_cleanrooms_en.pdf ↩
- Patheon/ Thermo Fisher. Technical guidance on high-shear granulation (Industry overview). https://www.thermofisher.com/ ↩
- FDA Warning Letter Database – Common citations related to equipment maintenance. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters ↩